Meeting

Hepatitis B Vaccine and Neurological Disorders


Committee Only


When:

Topics Children and Families, Public Health
Activity: Immunization Safety Review
Board: Board on Population Health and Public Health Practice

Welcome and Introduction
Marie McCormick, MD, ScD, Committee Chair

Clinical Description and Diagnosis of Multiple Sclerosis
Emmanuelle Waubant, MD
University of California, San Francisco Multiple Sclerosis Center
(co-author of commissioned paper posted on IOM website)

Pharmacovigilance and Case-Control Study of Hepatitis B Vaccine and Multiple Sclerosis
Bernard Begaud, MD, PhD (Presented via conference call)
Annie Fourrier, PharmD, MPH (Presented via conference call)
Universite Victor Segalen Bordeaux, France

Risk of Multiple Sclerosis Relapse after Immunization: European Database for Multiple Sclerosis
Samy Suissa, PhD
McGill University

Risk of Multiple Sclerosis after Hepatitis B Immunization: The Nurses' Health Study
Alberto Ascherio, MD, DrPH
Harvard University

Risk of Demyelinating Disease after Hepatitis B Vaccination: the Vaccine Safety Datalink
Frank DeStefano, MD, MPH
Centers for Disease Control and Prevention


Possible Mechanisms for Hepatitis B Vaccine-induced Multiple Sclerosis and Other Demyelinating Diseases
Emmanuelle Waubant, MD
University of California, San Francisco Multiple Sclerosis Center
(co-author of commissioned paper posted on IOM website)
*Dr. Waubant presented to the committee in two parts. All slides are available from the link for her first presentation.

Recommendations for Newborn and Infant Hepatitis B Vaccination Historical Perspective
Neal Halsey, MD
Johns Hopkins University

Recent Analyses of Hepatitis B Viral Infections in Children
Eric Mast, MD
National Center for Infectious Diseases
Centers for Disease Control and Prevention

Update on Communications Activities, National Immunization Program, Centers for Disease Control and Prevention
Glen Nowak, PhD
Centers for Disease Control and Prevention

Previous Meetings for this Activity

Also of Interest